Glenn E. Palomaki

20.2k total citations · 6 hit papers
255 papers, 14.2k citations indexed

About

Glenn E. Palomaki is a scholar working on Pediatrics, Perinatology and Child Health, Obstetrics and Gynecology and Infectious Diseases. According to data from OpenAlex, Glenn E. Palomaki has authored 255 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Pediatrics, Perinatology and Child Health, 54 papers in Obstetrics and Gynecology and 50 papers in Infectious Diseases. Recurrent topics in Glenn E. Palomaki's work include Prenatal Screening and Diagnostics (119 papers), Parvovirus B19 Infection Studies (50 papers) and Pregnancy and preeclampsia studies (42 papers). Glenn E. Palomaki is often cited by papers focused on Prenatal Screening and Diagnostics (119 papers), Parvovirus B19 Infection Studies (50 papers) and Pregnancy and preeclampsia studies (42 papers). Glenn E. Palomaki collaborates with scholars based in United States, Canada and United Kingdom. Glenn E. Palomaki's co-authors include James E. Haddow, George J. Knight, Jacob A. Canick, Wendy Y. Craig, Louis M. Neveux, Geralyn Lambert‐Messerlian, Josephine Williams, Edward M. Kloza, J E Haddow and Walter C. Allan and has published in prestigious journals such as New England Journal of Medicine, JAMA and The Journal of Immunology.

In The Last Decade

Glenn E. Palomaki

249 papers receiving 13.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the Child

1999 1.7k citations James E. Haddow, Glenn E. Palomaki et al. New England Journal of Medicine profile →
Maternal serum screening for Down's syndrome in early pregnancy.

1988 709 citations N J Wald, Howard Cuckle et al. BMJ profile →
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.

1989 680 citations Wendy Y. Craig, Glenn E. Palomaki et al. BMJ profile →
DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study

2011 660 citations Glenn E. Palomaki, Geralyn Lambert‐Messerlian et al. Genetics in Medicine profile →
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

2009 484 citations Linda Bradley, Glenn E. Palomaki et al. Genetics in Medicine profile →
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study

2012 392 citations Glenn E. Palomaki, Geralyn Lambert‐Messerlian et al. Genetics in Medicine profile →

Peers

Countries citing papers authored by Glenn E. Palomaki

Since Specialization

Citations

This map shows the geographic impact of Glenn E. Palomaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn E. Palomaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn E. Palomaki more than expected).

Fields of papers citing papers by Glenn E. Palomaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn E. Palomaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn E. Palomaki. The network helps show where Glenn E. Palomaki may publish in the future.

Co-authorship network of co-authors of Glenn E. Palomaki

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn E. Palomaki. A scholar is included among the top collaborators of Glenn E. Palomaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn E. Palomaki. Glenn E. Palomaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Numbers of prenatal cell‐free DNA screens performed: Results of a 2022 CAP exercise 2024 ·Prenatal Diagnosis ·Glenn E. Palomaki, Philip Wyatt, Ross Rowsey, (unknown), Nathalie Lepage, Marvin R. Natowicz, Thomas Long, Ann M. Moyer	1
2	International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies 2020 ·Prenatal Diagnosis ·Glenn E. Palomaki, Rossa W. K. Chiu, Mark D. Pertile, Erik A. Sistermans, Yuval Yaron, Joris Vermeesch, Neeta L. Vora, Robert G. Best, Louise Wilkins‐Haug	41
3	Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG) 2019 ·Genetics in Medicine ·Glenn E. Palomaki, Caleb Bupp, Anthony R. Gregg, Mary E. Norton, Devin Oglesbee, Robert G. Best	18
4	Relaxin-2 connecting peptide (pro-RLX2) levels in second trimester serum samples to predict preeclampsia 2017 ·Pregnancy Hypertension ·(unknown), Elizabeth Eklund, Joachim Struck, (unknown), Barbara O’Brien, Glenn E. Palomaki, Josef Köhrle, Andreas Bergmann, Geralyn Lambert‐Messerlian	9
5	Cut-off levels for hyperandrogenemia among Samoan women: An improved methodology for deriving normative data in an obese population 2016 ·Clinical Biochemistry ·(unknown), Geralyn Lambert‐Messerlian, Glenn E. Palomaki, Satupaitea Viali, Nicola L. Hawley, Stephen T. McGarvey	6
6	Molecular genetic testing for cystic fibrosis: laboratory performance on the College of American Pathologists external proficiency surveys 2014 ·Genetics in Medicine ·Elaine Lyon, Iris Schrijver, Karen E. Weck, Andrea Ferreira‐Gonzalez, C. Sue Richards, Glenn E. Palomaki	9
7	Molecular testing for the BRCA1 and BRCA2 Ashkenazi Jewish founder mutations: a report on the College of American Pathologists proficiency testing surveys 2014 ·Genetics in Medicine ·Laura J. Tafe, Michael Datto, Glenn E. Palomaki, Felicitas Lacbawan	13
8	Can Factor V Leiden and Prothrombin G20210A Testing in Women With Recurrent Pregnancy Loss Result in Improved Pregnancy Outcomes? Results From a Targeted Evidence-Based Review 2012 ·Obstetrical & Gynecological Survey ·Linda Bradley, Glenn E. Palomaki, Jessica L. Bienstock, Liz Varga, Joan Scott	1
9	Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy 2012 ·Genetics in Medicine ·Elaine Lyon, (unknown), Glenn E. Palomaki, Victoria M. Pratt, Kristen K. Reynolds, (unknown), Stuart A. Scott, Patrik Vitazka	34
10	Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review 2012 ·Genetics in Medicine ·Linda Bradley, Glenn E. Palomaki, Jessica L. Bienstock, Liz Varga, Joan Scott	32
11	Thyroperoxidase and Thyroglobulin Antibodies in Early Pregnancy and Placental Abruption 2011 ·Obstetrics and Gynecology ·James E. Haddow, Monica R. McClain, Glenn E. Palomaki, Louis M. Neveux, Geralyn Lambert‐Messerlian, Jacob A. Canick, Fergal D. Malone, T. Flint Porter, David A. Nyberg, Peter S. Bernstein, Mary E. D’Alton	18
12	Stability of first- and second-trimester serum markers after storage and shipment 2005 ·Prenatal Diagnosis ·Geralyn Lambert‐Messerlian, Elizabeth Eklund, Fergal D. Malone, Glenn E. Palomaki, Jacob A. Canick, Mary E. D’Alton	17
13	Screening of csytic fibrosis [3] (multiple letters) 1998 ·JAMA ·J E Haddow, Glenn E. Palomaki, Linda Bradley, (unknown), L. B. Holmes, Reed E. Pyeritz, Wynn Burke	7
14	Maternal serum screening for Down syndrome in the United States: A 1995 survey 1997 ·American Journal of Obstetrics and Gynecology ·Glenn E. Palomaki, George J. Knight, Jane McCarthy, James E. Haddow, (unknown)	98
15	Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropin 1995 ·Prenatal Diagnosis ·Glenn E. Palomaki, James E. Haddow, George J. Knight, (unknown), Anne Kennard, Jacob A. Canick, Devereux N. Saller, Miriam G. Blitzer, Lois H. Dickerman, Rachel Fisher, (unknown), M. Hansmann, David A. Luthy, Anne Summers, Philip Wyatt	94
16	Tay‐sachs disease in persons of French‐Canadian heritage in northern New England 1995 ·American Journal of Medical Genetics ·Glenn E. Palomaki, Josephine Williams, James E. Haddow, Marvin R. Natowicz	8
17	Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for Screening 1994 ·New England Journal of Medicine ·James E. Haddow, Glenn E. Palomaki, George J. Knight, George C. Cunningham, Linda S. Lustig, Patricia A. Boyd	162
18	Serum screening for Down's syndrome: Authors' reply 1989 ·BMJ ·N J Wald, Howard Cuckle, J. W. Densem, Kiran Nanchahal, Patrick Royston, T. Chard, J E Haddow, George J. Knight, Glenn E. Palomaki, Jacob A. Canick	1
19	Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. breakdown → 1989 ·BMJ ·Wendy Y. Craig, Glenn E. Palomaki, J E Haddow	680
20	Maternal serum screening for Down's syndrome in early pregnancy. breakdown → 1988 ·BMJ ·N J Wald, Howard Cuckle, J. W. Densem, Kiran Nanchahal, Patrick Royston, T. Chard, James E. Haddow, George J. Knight, Glenn E. Palomaki, Jacob A. Canick	709

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact